TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL.

MLA

Jain, Sneha S., et al. “Treatment Effect of Canagliflozin for Patients on Therapy for Heart Failure: Pooled Analysis of the Canvas Program and Credence Trial.” Journal of the American College of Cardiology (JACC), vol. 81, Mar. 2023, p. 283. EBSCOhost, https://doi.org/10.1016/S0735-1097(23)00727-1.

APA

Jain, S. S., Yu, J., Arnott, C., Neal, B. C., Perkovic, V., Neuen, B., Jardine, M., & Mahaffey, K. W. (2023). Treatment Effect of Canagliflozin for Patients on Therapy for Heart Failure: Pooled Analysis of the Canvas Program and Credence Trial. Journal of the American College of Cardiology (JACC), 81, 283. https://doi.org/10.1016/S0735-1097(23)00727-1

Chicago

Jain, Sneha S., Jie Yu, Clare Arnott, Bruce Charles Neal, Vlado Perkovic, Brendon Neuen, Meg Jardine, and Kenneth W. Mahaffey. 2023. “Treatment Effect of Canagliflozin for Patients on Therapy for Heart Failure: Pooled Analysis of the Canvas Program and Credence Trial.” Journal of the American College of Cardiology (JACC) 81 (March): 283. doi:10.1016/S0735-1097(23)00727-1.